Startup 64x Bio has secured $55 million in a financing round led by venture firm Lifeforce Capital to use its cell line-engineering technology to improve production of gene therapies now under ...

AI powerhouses Grok 3 and ChatGPT both predict that Mutuum Finance (MUTM) has a far greater chance of delivering a 64x return than Cardano (ADA) by 2026. While ADA, currently trading around $0.73 ...

64x Bio, a fledgling synthetic cell and gene therapy manufacturer, brought in $55 million in a series A round of fundraising. The company, which has about 10 employees and was founded in 2020 out ...